Jason Kralic is the founder of Tellus Therapeutics. Tellus Therapeutics has raised $35M in total funding. Latest round: Series A. Based in Durham, NC.
Jason Kralic is the Co-founder and CEO of Tellus Therapeutics, a preclinical life sciences startup focused on developing therapeutic interventions for critically ill newborns. He has led the company through seed funding and a $35 million Series A round to advance its lead candidate TT-20.
Full founder directory · Investor directory · Company funding database · Fundraising library